%0 Journal Article
%T Estimation of hepatocellular carcinoma mortality using aspartate aminotransferase to platelet ratio index
%A Allenson, Kelvin
%A Roife, David
%A Kao, Lillian S.
%A Ko, Tien C.
%A Wray, Curtis J.
%J Journal of Gastrointestinal Oncology
%D 2018
%B 2018
%9 
%! Estimation of hepatocellular carcinoma mortality using aspartate aminotransferase to platelet ratio index
%K 
%X Background: Hepatocellular carcinoma (HCC) patients with cirrhosis are high-risk for invasive procedures. Identification of those at risk may prevent complications and allow more informed decision-making. The aspartate aminotransferase (AST) to platelet ratio index (APRI) is a measure of cirrhosis that we hypothesize predicts survival and may estimate HCC mortality.  Methods: Institutional retrospective study of all HCC patients. Demographics and labs [bilirubin, international normalized ratio (INR), creatinine, AST and platelets] were recorded at the date-of-diagnosis to calculate APRI and the Model for End-Stage Liver Disease score (MELD). Poor survival was defined as death within 30-days from diagnosis. Models were created to determine predictors of death within 30-days and overall survival.   Results: A total of 829 patients comprised this study and 
%U https://jgo.amegroups.org/article/view/25308
%V 11
%N 2
%P 291-297
%@ 2219-679X